Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
CG Oncology, Inc. market cap for the quarter ending 2026-08-05 was $6.41B, a 232.60% increase year-over-year.
CG Oncology, Inc. market cap for the quarter ending 2026-06-30 was $6.27B, a 216.50% increase year-over-year.
CG Oncology, Inc. market cap for the quarter ending 2026-05-06 was $6B, a 231.42% increase year-over-year.
CG Oncology, Inc. market cap for the quarter ending 2026-03-31 was $5.96B, a 219.42% increase year-over-year.
CG Oncology, Inc. market cap for fiscal 2026 was $6.41B.
CG Oncology, Inc. market cap for fiscal 2025 was $3.35B, a 53.54% increase from fiscal 2024.
CG Oncology, Inc. market cap for fiscal 2024 was $2.18B.